- Home
- OGI vs STXS Comparison
OGI vs STXS Comparison
Compare OGI & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- STXS
- Stock Information
- Founded
- OGI 2013
- STXS 1990
- Country
- OGI Canada
- STXS United States
- Employees
- OGI N/A
- STXS N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- OGI Health Care
- STXS Health Care
- Exchange
- OGI Nasdaq
- STXS Nasdaq
- Market Cap
- OGI 186.1M
- STXS 151.3M
- IPO Year
- OGI N/A
- STXS 2004
- Fundamental
- Price
- OGI $1.53
- STXS $2.25
- Analyst Decision
- OGI
- STXS
- Analyst Count
- OGI 0
- STXS 0
- Target Price
- OGI N/A
- STXS N/A
- AVG Volume (30 Days)
- OGI 599.7K
- STXS 334.1K
- Earning Date
- OGI 08-12-2025
- STXS 08-07-2025
- Dividend Yield
- OGI N/A
- STXS N/A
- EPS Growth
- OGI N/A
- STXS N/A
- EPS
- OGI 0.10
- STXS N/A
- Revenue
- OGI $135,031,829.00
- STXS $27,510,000.00
- Revenue This Year
- OGI $50.30
- STXS $25.90
- Revenue Next Year
- OGI $16.01
- STXS $60.57
- P/E Ratio
- OGI $14.76
- STXS N/A
- Revenue Growth
- OGI 20.49
- STXS 1.50
- 52 Week Low
- OGI $0.85
- STXS $1.54
- 52 Week High
- OGI $2.08
- STXS $2.72
- Technical
- Relative Strength Index (RSI)
- OGI 61.28
- STXS 51.14
- Support Level
- OGI $1.43
- STXS $2.21
- Resistance Level
- OGI $1.59
- STXS $2.32
- Average True Range (ATR)
- OGI 0.06
- STXS 0.11
- MACD
- OGI 0.01
- STXS -0.01
- Stochastic Oscillator
- OGI 75.56
- STXS 34.52
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.